Your browser doesn't support javascript.
loading
NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia.
Hof, Jana; Kox, Corinne; Groeneveld-Krentz, Stefanie; Bandapalli, Obul R; Karawajew, Leonid; Schedel, Katharina; Kunz, Joachim B; Eckert, Cornelia; Ludwig, Wolf-Dieter; Ratei, Richard; Rhein, Peter; Henze, Günter; Muckenthaler, Martina U; Kulozik, Andreas E; von Stackelberg, Arend; Kirschner-Schwabe, Renate.
Afiliação
  • Hof J; Department of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
  • Kox C; German Cancer Consortium (DKTK), and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Groeneveld-Krentz S; Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany.
  • Bandapalli OR; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.
  • Karawajew L; European Molecular Biology Laboratory (EMBL), Heidelberg, Germany.
  • Schedel K; Department of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
  • Kunz JB; Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany.
  • Eckert C; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.
  • Ludwig WD; Department of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
  • Ratei R; Department of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
  • Rhein P; Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany.
  • Henze G; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.
  • Muckenthaler MU; Department of Pediatrics, Division of Oncology and Hematology, Charité - University Medical Center Berlin.
  • Kulozik AE; German Cancer Consortium (DKTK), and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • von Stackelberg A; HELIOS Medical Clinic Berlin-Buch, Clinic for Hematology, Oncology, Tumor Immunology and Palliative Care, Berlin.
  • Kirschner-Schwabe R; HELIOS Medical Clinic Berlin-Buch, Clinic for Hematology, Oncology, Tumor Immunology and Palliative Care, Berlin.
Haematologica ; 102(7): e249-e252, 2017 07.
Article em En | MEDLINE | ID: mdl-28360149
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteína Supressora de Tumor p53 / Receptor Notch1 / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Mutação Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteína Supressora de Tumor p53 / Receptor Notch1 / Leucemia-Linfoma Linfoblástico de Células T Precursoras / Mutação Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article